NASDAQ:TRVI

Trevi Therapeutics, Inc.

Stock

USD

Last Close

11.01

06/11 21:06

Market Cap

186.65M

Beta: 0.69

Volume Today

1.81M

Avg: 82.90K

PE Ratio

−5.22

PFCF: −2.81

Overview Financials API

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-12.86M -	-20.55M 59.76%	-26.05M 26.79%	-32.76M 25.75%	-33.94M 3.61%	-29.15M 14.11%	-29.07M 0.30%
depreciation and amortization	4K -	23K 475%	39K 69.57%	47K 20.51%	50K 6.38%	43K 14.00%	123K 186.05%
deferred income tax	1.35M -			9K -	-82K 1,011.11%
stock based compensation	205K -	496K 141.95%	1.13M 127.22%	2.42M 114.46%	2.54M 5.21%	2.33M 8.49%	2.25M 3.44%
change in working capital	722K -	-568K 178.67%	1.58M 377.46%	1.06M 32.87%	1.51M 42.63%	-1.23M 181.58%	-1.05M 14.78%
accounts receivables			-374K -	293K 178.34%
inventory			374K -	-293K 178.34%
accounts payables	92K -	66K 28.26%	777K 1,077.27%	417K 46.33%	831K 99.28%	9K 98.92%	-1.05M 11,755.56%
other working capital	630K -	-634K 200.63%	799K 226.03%	641K 19.77%	678K 5.77%	-1.24M 282.89%	1.05M 184.60%
other non cash items	2.60M -	2.30M 11.49%	215K 90.66%	227K 5.58%	974K 329.07%	-162K 116.63%	-5.01M 2,995.68%
net cash provided by operating activities	-7.97M -	-18.29M 129.35%	-23.09M 26.25%	-29M 25.58%	-28.95M 0.19%	-28.18M 2.66%	-31.71M 12.55%
investments in property plant and equipment	-13K -	-158K 1,115.38%	-9K 94.30%	-32K 255.56%		-159K -	-137K 13.84%
acquisitions net						-829K -
purchases of investments						-126.22M -	-9.93M 92.13%
sales maturities of investments						19.00M -	67.37M 254.57%
other investing activites						829K -	2.13M 156.33%
net cash used for investing activites	-13K -	-158K 1,115.38%	-9K 94.30%	-32K 255.56%		-107.37M -	59.43M 155.35%
debt repayment	-8.25M -	-5.34M 35.22%	-2.24M 58.10%	-13.92M 521.53%	-68K 99.51%	-5.83M 8,477.94%	-95K 98.37%
common stock issued			65.10M -	3.13M 95.18%	21.18M 575.69%	105.41M 397.62%
common stock repurchased			-1.21M -
dividends paid			-2.24M -
other financing activites	29.97M -	8.97M 70.06%	13.80M 53.81%	27.50M 99.22%	-340K 101.24%	11.73M 3,550%	-7.82M 166.62%
net cash used provided by financing activities	21.72M -	3.63M 83.28%	73.21M 1,916.33%	16.72M 77.16%	20.77M 24.25%	111.31M 435.77%	-7.91M 107.11%
effect of forex changes on cash
net change in cash	13.73M -	-14.82M 207.89%	50.11M 438.18%	-12.31M 124.57%	-8.17M 33.63%	-24.24M 196.67%	19.81M 181.71%
cash at beginning of period	8.29M -	22.02M 165.75%	7.20M 67.29%	57.31M 695.79%	45.00M 21.48%	36.83M 18.16%	12.59M 65.82%
cash at end of period	22.02M -	7.20M 67.29%	57.31M 695.79%	45.00M 21.48%	36.83M 18.16%	12.59M 65.82%	32.40M 157.34%
operating cash flow	-7.97M -	-18.29M 129.35%	-23.09M 26.25%	-29M 25.58%	-28.95M 0.19%	-28.18M 2.66%	-31.71M 12.55%
capital expenditure	-13K -	-158K 1,115.38%	-9K 94.30%	-32K 255.56%		-159K -	-137K 13.84%
free cash flow	-7.99M -	-18.45M 130.96%	-23.10M 25.22%	-29.03M 25.67%	-28.95M 0.30%	-28.33M 2.11%	-31.85M 12.40%

All numbers in USD (except ratios and percentages)